Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

BOSTON SCIENTIFIC CORPORATION

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer

Not Applicable

Completed

Conditions: Colorectal Cancer Metastatic

Interventions: Device: TheraSphere

First Posted Date: 2011-12-01

Last Posted Date: 2022-03-29

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 428

Registration Number: NCT01483027

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
University of California San Fransico, Moffitt Hospital, San Francisco, California, United States
🇺🇸
University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado, United States

and more 128 locations

Prevention of Syncope by Cardiac Pacing in Patients With Bifascicular Block

Not Applicable

Completed

Conditions: Bifascicular Block
Syncope

Interventions: Device: DDD60 (INSIGNIA® pacing systems Guidant (Boston Scientific)

First Posted Date: 2011-11-01

Last Posted Date: 2021-04-19

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 101

Registration Number: NCT01463358

Locations: 🇮🇹
Ospedale Santa Maria Annunziata, Bagno a Ripoli, Italy
🇮🇹
Azienda Ospedaliera S. Sebastiano, Caserta, Italy
🇮🇹
Ospedale Valduce, Como, Italy

and more 9 locations

Safety and Efficacy of Cryoablation for the Palliation of Painful Bone Metastases

Phase 1

Completed

Conditions: Neoplasm Metastasis
Pain

Interventions: Procedure: Cryoablation

First Posted Date: 2011-10-28

Last Posted Date: 2021-07-16

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 29

Registration Number: NCT01461265

Locations: 🇺🇸
Karmanos Cancer Institute, Detroit, Michigan, United States
🇺🇸
University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States
🇨🇦
University of British Columbia, Vancouver, British Columbia, Canada

and more 1 locations

Safety and Efficacy of Cryoablation Combined With Radiation Therapy for the Palliation of Painful Bone Metastases

Phase 1

Withdrawn

Conditions: Neoplasm Metastasis
Pain

Interventions: Procedure: Cryoablation
Procedure: Radiation

First Posted Date: 2011-10-28

Last Posted Date: 2021-07-16

Lead Sponsor: Boston Scientific Corporation

Registration Number: NCT01461252

Ingenio Device Algorithm Study

Not Applicable

Completed

Conditions: Sinus Node Disease
AV Block
Heart Failure

Interventions: Device: RAAT
Device: RYTHMIQ

First Posted Date: 2011-09-27

Last Posted Date: 2024-03-21

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 139

Registration Number: NCT01441583

Locations: 🇦🇹
Wilhelminenspital, Vienna, Austria
🇦🇹
Landesklinikum Wiener Neustadt, Wiener Neustadt, Austria
🇧🇪
Clinique Universitaires Saint Luc, Brussels, Belgium

and more 18 locations

The Jetstream (JET) Post-market Registry

Phase 4

Completed

Conditions: Peripheral Arterial Diseases

Interventions: Device: Jetstream Atherectomy System

First Posted Date: 2011-09-19

Last Posted Date: 2016-10-19

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 241

Registration Number: NCT01436435

Locations: 🇺🇸
Nelson Bernardo MD, Washington DC, District of Columbia, United States
🇺🇸
Robert Beasley, MD, Miami, Florida, United States
🇺🇸
Nicolas Shammas, MD, Davenport, Iowa, United States

and more 8 locations

The ACE Follow-up Study

Not Applicable

Completed

Conditions: Obesity

Interventions: Procedure: ACE Stapler

First Posted Date: 2011-09-07

Last Posted Date: 2015-06-16

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 69

Registration Number: NCT01429194

Locations: 🇦🇷
Hospital Aleman / Programa de Unidades Bariátricas, Autonoma de Bueno Aires, Argentina
🇦🇷
Hospital Italiano de Mendoza / Clinica Quirugica S. A., Mendoza, Argentina
🇨🇦
University Institute of Cardiology and Pulmonary Medicine of Quebec, Quebec, Canada

and more 3 locations

Pharmacokinetic Study of Polidocanol Endovenous Microfoam (PEM)

Phase 1

Completed

Conditions: Varicose Veins

Interventions: Drug: Polidocanol Endovenous Microfoam (PEM)

First Posted Date: 2011-09-02

Last Posted Date: 2021-04-21

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 21

Registration Number: NCT01428076

Locations: 🇺🇸
Cardiovascular and Vein Center of Florida, Bradenton, Florida, United States

ION US Post-Approval Study

Completed

Conditions: Atherosclerosis
Coronary Artery Disease

Interventions: Device: ION™ Coronary Stent System

First Posted Date: 2011-08-25

Last Posted Date: 2016-02-04

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 1120

Registration Number: NCT01422889

Locations: 🇺🇸
NEA Baptist Memorial Hospital, Jonesboro, Arkansas, United States
🇺🇸
St. Bernard's Medical Center, Jonesboro, Arkansas, United States
🇺🇸
Bakersfield Memorial Hospital, Bakersfield, California, United States

and more 37 locations

Evaluation of Physiologic Parameters to Study the Mechanism of Action of the Lung Volume Reduction Coil in Subjects With Homogeneous Emphysema

Phase 2

Completed

Conditions: Emphysema

Interventions: Device: Lung Volume Reduction Coil (LVRC) (PneumRx, Inc.)

First Posted Date: 2011-08-22

Last Posted Date: 2021-07-16

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 10

Registration Number: NCT01421082

Locations: 🇳🇱
University Medical Center Groningen - UMCG, Groningen, The Netherlands, Netherlands

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy